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ABSTRACT  25 
 2
 26 
Purpose: To measure depth-specific riboflavin concentrations in corneal 27 
stroma using two-photon fluorescence microscopy and compare commercially 28 
available transepithelial corneal collagen cross-linking (CXL) protocols. 29 
 30 
Methods: Transepithelial CXL riboflavin preparations – MedioCross TE, 31 
Ribocross TE, Paracel plus VibeX Xtra and Iontophoresis with Ricrolin Plus – 32 
were applied to the corneal surface of fresh postmortem rabbit eyes in 33 
accordance with manufacturers’ recommendations for clinical use. Riboflavin 34 
0.1% (Vibex Rapid) was applied after corneal epithelial debridement as a 35 
positive control.  36 
 37 
After riboflavin application, eyes were snap frozen in liquid nitrogen. 35µm 38 
thick corneal cross-sections were cut on a cryostat, mounted on a slide and 39 
imaged by two-photon fluorescence microscopy. Mean (SD) concentrations 40 
were calculated from 5 globes tested for each protocol. 41 
 42 
Results: Peak riboflavin concentration of 0.09 % (± 0.01) was observed within 43 
the most superficial stroma (stromal depth 0 - 10 µm) in positive controls 44 
(epithelium-off). At the same depth, peak stromal riboflavin concentrations for 45 
Mediocross TE, Ricrolin +, Paracel/Xtra and Ribocross TE were: 0.054 % (± 46 
0.01), 0.031 % (0.003), 0.021 % (± 0.001) and 0.015 % (± 0.004) respectively.  47 
 48 
At a depth of 300 µm (within the demarcation zone commonly seen after 49 
corneal cross-linking), the stromal concentration in epithelium-off positive 50 
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controls was 0.075 % (± 0.006), while at the same depth MedioCross TE and 51 
Ricrolin + achieved 0.018 % (± 0.006) and 0.016 % (0.002) respectively. None 52 
of the remaining transepithelial protocols achieved concentrations above 53 
0.005% at this same 300 µm depth. Overall, MedioCross TE was the best 54 
performing transepithelial formulation. 55 
 56 
Conclusions: Corneal epithelium is a significant barrier to riboflavin 57 
absorption into the stroma. Existing commercial transepithelial CXL protocols 58 
achieve relatively low riboflavin concentrations in the anterior corneal stroma 59 
when compared to gold-standard epithelium-off absorption. Reduced stromal 60 
riboflavin concentration may compromise the efficacy of riboflavin/ultraviolet 61 
corneal CXL. 62 
 63 
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INTRODUCTION 73 
 74 
 4
Corneal collagen cross-linking (CXL), using the original ‘Dresden’ epithelium-75 
off protocol1 is effective in arresting disease progression in keratoconus in 76 
over 90% of eyes.2–4 The corneal epithelium is removed in this protocol to 77 
facilitate riboflavin absorption and hence treatment efficacy. However, 78 
complications including infection, scarring, delayed healing, sterile 79 
inflammatory infiltration, tissue melting and resultant vision loss have all been 80 
described in association with corneal epithelial removal in CXL.5 Due to these 81 
complications, CXL is normally reserved for patients with demonstrable 82 
disease progression. 83 
 84 
Transepithelial CXL, in which riboflavin is applied through an intact epithelium, 85 
aims to deliver the benefits of standard epithelium-off treatments without the 86 
painful rehabilitation and complications of epithelial removal. However, the 87 
only published randomised controlled trial of this newer technique6 recently 88 
concluded it was not effective compared with epithelium-off CXL. Most 89 
commercially-available riboflavin formulations for transepithelial CXL are 90 
designed to enhance epithelial permeability by the addition of epithelial-toxic 91 
agents (table 1). Another method involves iontophoresis, in which negatively-92 
charged riboflavin is driven through the epithelium down an electrical 93 
gradient.7–9 94 
 95 
Previous studies to quantify riboflavin penetration through an intact epithelium 96 
have used high-performance liquid chromatography (HPLC)10–12 and 97 
fluorescence microscopy.13–17 HPLC, in which the sample is dissolved in a 98 
solvent for analysis, can accurately quantify the concentration of riboflavin in a 99 
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whole block of tissue, but is unable to provide information about the 100 
concentration at different depths within the corneal stroma (unless lamella 101 
sections are prepared and separately dissolved).18 Fluorescence microscopy, 102 
both single-photon excitation (i.e. confocal) and multi-photon excitation13–17 103 
has the added advantage of quantifying concentration at depth within the 104 
cornea; both excitation techniques, however, suffer from signal attenuation 105 
with increasing scan depth, principally attributable to scattering and 106 
aberration.14–16 We have previously reported14 a novel time-lapse 107 
measurement approach to correct for two-photon fluorescence (TPF) signal 108 
attenuation; although applicable to epithelium-off absorption, this method has 109 
not proven suitable when imaging through an intact epithelium.19 110 
 111 
Here we describe a new method for quantifying riboflavin concentration within 112 
the cornea using an ex vivo animal rabbit eye model and compare the efficacy 113 
of current commercially available protocols for transepithelial CXL in 114 
promoting riboflavin absorption.  115 
 116 
 117 
 118 
 119 
 120 
MATERIALS AND METHODS 121 
 122 
 6
Ethical approval for corneal two-photon fluorescent microscopy studies in an 123 
ex vivo model was granted by University College London Institute of 124 
Ophthalmology (ref. 10/H0106/57-2012ETR27). 125 
 126 
Sample preparation 127 
Adult pigmented rabbit heads transported on ice in a phosphate buffered 128 
saline (PBS) bath were received within 5 hours post-mortem (First Link Ltd., 129 
Wolverhampton, UK). Intact globes were enucleated and examined under a 130 
low-magnification light microscope to rule out obvious epithelial trauma or 131 
scars. The globes were warmed to room temperature in balanced salt solution 132 
before different commercially-available riboflavin solutions (table 1) were 133 
applied to the corneas according to the manufacturers’ protocols. Corneas 134 
soaked for 30 minutes with 0.1 % riboflavin in HPMC and saline (VibeX Rapid, 135 
Avedro, Inc) after epithelial debridement served as positive controls and 136 
unsoaked corneas served as negative controls. 137 
 138 
Commercial transepithelial CXL protocols we compared were (n=5 for each 139 
protocol): 140 
1. Medio-Cross TE (Peschke Meditrade GmbH, Germany)  141 
A 9 mm vacuum well secured on the cornea was filled with approximately 0.5 142 
ml of Medio-Cross TE solution for 30 minutes. Riboflavin was not rinsed from 143 
the cornea. 144 
2. Ribocross TE (IROS Srl, Napoli, Italy) 145 
A 9 mm vacuum well secured on the cornea was filled with approximately 0.5 146 
ml of Ribocross TE solution for 30 minutes. Riboflavin was not rinsed from the 147 
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cornea. 148 
3. ParaCel and VibeX Xtra (Avedro, Inc., Waltham, MA, USA)  149 
ParaCel drops were applied at a rate of 1 drop every 90 seconds for 4 150 
minutes. The cornea was then rinsed with VibeX Xtra completely coating the 151 
cornea. Additional VibeX Xtra was applied at a rate of 1 drop every 90 152 
seconds for 6 minutes (total riboflavin soak time 10 minutes). Riboflavin was 153 
not rinsed from the cornea. 154 
4. Ricrolin+ (Sooft Italia S.p.A. Montegiorgio, Italy)  155 
The iontophoresis system comprised 2 electrodes: a negatively-charged metal 156 
grid housed within the corneal applicator and a positively-charged 20G needle 157 
inserted through the sclera into the vitreous. The corneal applicator was 158 
vacuum-attached to the cornea. The reservoir was filled with Ricrolin + above 159 
the level of the metal grid before beginning a 5 minute treatment with a 160 
continuous direct current of 1 mA (figure 1A). After the iontophoretic 161 
procedure, the applicator was removed and riboflavin rinsed from the cornea. 162 
 163 
Section preparation 164 
At the end of the riboflavin soak, the globes were immediately immersed in 165 
liquid nitrogen for 5 minutes and stored overnight at -25 degrees Celsius. A 166 
broad incision across the posterior globe was made just before immersion to 167 
prevent the cornea from splitting open on freezing. For each globe, three 168 
35 µm corneal cross-sections were cut on a cryostat 1 mm apart 169 
(Supplementary Fig. S1). With the frozen section on the blade platform 170 
(maintained at -21°C), a knife was used to cut the cornea free and the 171 
remaining tissue was brushed away. The cornea itself was meticulously 172 
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brushed to ensure no ice remained attached that might allow riboflavin to leak 173 
out once thawed. The corneal section was then mounted on a slide and 174 
covered with fluorescence-free immersion oil (Immersol 518 F, Carl Zeiss 175 
Ltd.) to prevent any leakage of riboflavin out of the tissue. A coverslip was 176 
placed on top prior to imaging under the microscope objective (figure 1B). The 177 
time taken from the tissue thawing onto the slide to image acquisition on the 178 
microscope was approximately 1 minute, and we refer to this earliest imaging 179 
time point as t = 0 minutes. To investigate riboflavin migration within the 180 
thawed slide-mounted tissue, serial images were captured every minute for 181 
selected samples. For all other measurements, data was acquired as soon as 182 
possible following tissue thawing, i.e. after approximately 1 minute. 183 
 184 
Two-photon microscope set-up and imaging protocol 185 
We have previously described the use of two-photon fluorescence (TPF) 186 
microscopy for imaging corneal cross-sections.14 In brief, a Ti:Sapphire laser, 187 
operating at a wavelength of 890 nm with a 140 femtosecond pulse duration 188 
and 80 MHz pulse repetition rate,  was used as the excitation laser source. 189 
The excitation laser beam was guided to a Leica DM6000CS upright 190 
microscope where it passes through two galvoscanners, allowing scanning in 191 
the x-y plane, before being focused into the sample by a Leica 10 X /0.3 NA 192 
water immersion objective. Theoretical (full-width half-maximum) axial and 193 
lateral resolutions were calculated at 16 µm and 1.1 µm respectively. TPF 194 
excitation light of 890 nm wavelength was chosen to correspond with the 195 
highest riboflavin absorption peak (445 nm) as determined by 196 
spectrophotometry. Emitted riboflavin fluorescence was collected between 197 
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525 nm and 650 nm to avoid overlap with the absorption spectrum of 198 
riboflavin. 553 µm x 553 µm (512 x 512 pixel) images were captured at a scan 199 
rate of 600 Hz (line average 16) with the pinhole wide open.  200 
 201 
Image analysis 202 
Grey scale images (figure 1C) were exported and analysed using Java-based 203 
imaging software (ImageJ, 1.48v, http:// imagej.nih.gov.ij; provided in the 204 
public domain by the National Institutes of Health, Bethesda, MD, USA). For 205 
each image, three separate rectangular regions of interest each 40 pixels 206 
wide in the x-direction (see figure 1C) were manually selected.  The intensity 207 
profiles along the z-direction for each region of interest were then exported to 208 
a .txt file (Excel for Mac, 2011; Microsoft Corp, Redmond, WA, USA) (figure 209 
1D). The epithelial/stromal junction was then identified in each trace by the 210 
abrupt change in signal and confirmed with reference to the corresponding 211 
image region of interest. This information was then used to align all three plots 212 
along the z-axis and a mean intensity plot was then generated representing 213 
the average TPF signal for that image as a function of depth (z). TPF signals 214 
were converted to riboflavin concentration by normalizing to the TPF signal 215 
achieved in a well-slide reservoir of 0.1 % riboflavin solution during the same 216 
experimental session. Mean (SD) concentrations were calculated from 5 217 
globes tested for each protocol. 218 
 219 
 220 
RESULTS 221 
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 222 
Riboflavin migration within thawed tissue 223 
Serial images were captured at time = 0, 1 and 2 minutes (t = 0 being the first 224 
scan approximately 1 minute after the tissue thawed on the slide). Figure 2 225 
confirms fluorophore migration within the sample, redistributing posteriorly 226 
with time including from the epithelium into the underlying stroma. Measured 227 
at the beginning of the stroma, this drop in signal is approximately 7% within 228 
the first minute. Therefore, all subsequent data was acquired as soon as 229 
possible following thawing, i.e. after approximately 1 minute. 230 
 231 
Depth-specific corneal riboflavin absorption 232 
No fluorescence was detected by TPF microscopy in the negative (untreated) 233 
controls. The maximum riboflavin concentration in positive controls 234 
(epithelium-off) was 0.09 % (± 0.01). Maximum stromal riboflavin 235 
concentrations for Mediocross TE, Ricrolin +, Paracel/Xtra and Ribocross TE 236 
were: 0.054 % (± 0.01), 0.031 % (0.003), 0.021 % (± 0.001) and 0.015 % (± 237 
0.004) respectively. Depth-specific riboflavin concentrations are displayed in 238 
figures 3-5. Stromal absorption of riboflavin by iontophoresis was not 239 
homogenous, with areas of relative hypo- and hyper fluorescence within each 240 
section. In all samples, the epithelial concentration was higher than that in the 241 
underlying stroma. A film of higher signal riboflavin adherent to the epithelium 242 
was detected in samples treated with Ribocross TE.  243 
 244 
 At a depth of 300 µm (within the demarcation zone commonly seen after 245 
corneal cross-linking), the stromal concentration in epithelium-off positive 246 
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controls was 0.075 % (± 0.006), while at the same depth MedioCross TE  247 
and Ricrolin + achieved 0.018 % (± 0.006) and 0.016 % (0.002) respectively. 248 
None of the remaining transepithelial protocols achieved concentrations 249 
above 0.005% at this same 300 µm depth. 250 
 251 
 252 
DISCUSSION 253 
 254 
These data suggest that absorption of riboflavin into the corneal stroma is 255 
significantly reduced in current commercial transepithelial CXL protocols in 256 
comparison with epithelium-off CXL.  257 
 258 
Since most tissue cross-linking is thought to take place in the anterior 259 
cornea,20 determining the availability of key photochemical ingredients 260 
(riboflavin, UV light, oxygen) at specific depths may add useful additional 261 
information. The method we describe above provides these depth-specific 262 
measurements of riboflavin, with the microscope objective and image size 263 
determining the resolution available. An additional advantage of our technique 264 
is the ability to quantify riboflavin concentration within the epithelium which, as 265 
our results demonstrate, exceeds that in the underlying stroma. In clinical 266 
practice, the consequences of loading the corneal epithelium with riboflavin in 267 
transepithelial CXL could include epithelial toxicity and UV light shielding. The 268 
normal epithelium filters out an average 20% of UVA light radiation passing 269 
through the cornea.20 This UV light attenuation is increased by riboflavin 270 
absorption within the epithelium in transepithelial CXL, and stromal 271 
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concentrations of riboflavin are reduced. Enhanced UV absorption with free 272 
radical generation within the epithelium could result in ‘arc eye’ type epithelial 273 
toxicity. Epithelial defects are commonly observed on day 1 after 274 
transepithelial CXL using currently available protocols,21 and punctate 275 
epithelialopathy is evident in all cases (personal communication, David 276 
O’Brart, February 2015). 277 
 278 
The inability to measure concentration at specific depths in the epithelium and 279 
stroma is a significant limitation of HPLC. Furthermore, unless this riboflavin-280 
rich epithelium is specifically removed prior to dissolving the sample, the 281 
concentration result will be inappropriately increased. This may have 282 
contributed to the observations described by Ostacolo et al.11 in which 283 
Ribocross TE was tested using modified Franz-type diffusion cells with freshly 284 
excised porcine corneas (both with and without epithelium). After 40 minutes, 285 
riboflavin accumulation through an intact epithelium (0.394 ± 0.02 nmol/mg) 286 
matched that achieved epithelium-off (0.396 ± 0.03 nmol/mg). This contrasts 287 
with our results in which Ribocross TE performed poorly compared to other 288 
protocols tested. As demonstrated in figures 4 & 5, we observed TFP signals 289 
within the epithelium to be higher than in the underlying stroma in all tested 290 
protocols. Furthermore, the pre-corneal film of riboflavin solution exhibited 291 
even higher fluorescence signal. Dissolving a full-thickness specimen, 292 
including a riboflavin-loaded epithelium and pre-corneal film, will lead to 293 
overestimation of corneal stromal riboflavin concentrations by HPLC. This 294 
may explain why Ostacolo et al.11 recorded only a 4-fold reduction in stromal 295 
concentration when their control riboflavin solution (i.e. no vitamin E) was 296 
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applied to an intact epithelium, compared with epithelium-off application 297 
(0.098 ± 0.04 nmol/mg epithelium-on; 0.396 ± 0.03 nmol/mg epithelium-off). 298 
Cassagne et al.12 also used HPLC in an in vivo rabbit eye study of 299 
iontophoresis, testing both the dissolved cornea and aqueous sample. Again, 300 
the investigators did not remove the epithelium prior to analysis. This may, in 301 
part, explain the discrepancy in their results in which they observed 45% less 302 
riboflavin in corneas treated using iontophoresis (compared to epithelium-off 303 
controls), but 95% less riboflavin in the aqueous of iontophoresis treated 304 
eyes. 305 
 306 
There are a number of limitations to this study. Firstly, results in ex-vivo rabbit 307 
corneas, although a better anatomical match to human corneal epithelial 308 
thickness than porcine eyes, may be affected by post-mortem changes in 309 
epithelial layer integrity. Measures taken to minimize this compromise 310 
included a short postmortem interval, immersion in chilled PBS immediately 311 
postmortem, and warming to physiological temperature prior to preparation of 312 
corneas for experimentation. We observed no obvious stromal swelling 313 
(indicative of endothelial pump failure) in negative controls, and mean corneal 314 
thicknesses to those published for rabbit corneas in vivo (400 µm).22 Despite 315 
this, some epithelial degradation and enhanced permeability is likely, and our 316 
results may overestimate stromal riboflavin absorption in clinical 317 
transepithelial CXL. Secondly, migration of riboflavin within the snap frozen 318 
tissue will have started as soon as the section thawed on the slide. Even with 319 
the cryostat next to the microscope, there was still a delay of up to a minute 320 
before image acquisition. This would tend to result in an underestimation of 321 
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stromal riboflavin concentrations. Finally, imaging through two media of 322 
different refractive indices (oil and water either side of the coverslip) may have 323 
increased optical aberrations as the laser light passes through. We chose oil 324 
to ensure no (water soluble) riboflavin leaked out of the tissue. When we tried 325 
to embed excised corneas in optimal cutting temperature (OCT) compound 326 
we observed very prompt dye leakage once thawed on the slide (data not 327 
shown). This may have impacted the study of Cassagne et al.12. For lack of 328 
an appropriate oil-immersion objective, we placed a coverslip on top and used 329 
a water-immersion objective. Any induced aberrations may have resulted in a 330 
small absolute loss of signal; but since this same method was employed for all 331 
imaged samples, no relative drop between samples should be present.  332 
 333 
Notwithstanding the above laboratory studies, results from preliminary clinical 334 
case series using non-iontophoretic transepithelial riboflavin preparations 335 
have been equivocal, with some showing similar efficacy to epithelium-off 336 
CXL,23,24 whilst most have demonstrated less pronounced effects.25–27,6,28 12-337 
month results from one recently published randomised controlled trial6 338 
concluded that transepithelial CXL using Ricrolin TE (Sooft Italia S.p.A. 339 
Montegiorgio, Italy) was not effective at stabilising corneal shape compared 340 
with epithelium-off treatment. For iontophoresis, up to 15 month follow-up data 341 
have been published, with reported cessation of disease progression and 342 
improvements in keratometric and visual parameters.7–9 The longer-term 343 
relative efficacy of all these transepithelial techniques compared to epithelium-344 
off CXL remains unknown. 345 
 346 
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In conclusion, the methodology described above provides a quantitative 347 
means of measuring riboflavin across the whole cornea in an ex vivo model. 348 
We present evidence that the corneal epithelium represents a significant 349 
barrier to riboflavin absorption into the stroma. Existing commercial 350 
transepithelial CXL protocols load the corneal epithelium with riboflavin and 351 
achieve relatively low riboflavin concentrations in the anterior corneal stroma 352 
when compared to epithelium-off CXL. Although a key rate-limiting step, the 353 
absolute stromal concentration of riboflavin required for effective CXL is not 354 
known. Without further evidence, the concentration achieved ‘epithelium-off’ 355 
remains the gold standard. The differences in transepithelial absorption 356 
demonstrated above may yield different degrees of tissue cross-linking and 357 
are, therefore, likely to be clinically significant. The method described above 358 
may prove useful in testing candidate protocols prior to future clinical trials. 359 
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Table 1 Commercially available riboflavin preparations 
 
Riboflavin  
formulation 
Composition 
Vibex Rapid 0.1% wt/vol riboflavin 5’-monophosphate, saline, HPMC 
Ribocross TE 
 
0.125% wt/vol riboflavin 5’-monophosphate,    
D-alpha-tocopheryl poly(ethylene glycol) 1000 succinate 
Medio-Cross TE  
 
0.25% wt/vol riboflavin 5’-monophosphate, HPMC, 
benzalkonium chloride 0.01% 
Ricrolin +  
 
0.1% wt/vol riboflavin 5’-monophosphate, sodium edetate, 
trometamol, sodium dihydrogen phosphate dihydrate, 
sodium phosphate dibasic dehydrate 
ParaCel  
 
0.25% wt/vol riboflavin 5’-monophosphate, HPMC, sodium 
edetate, trometamol, benzalkonium chloride, saline 
VibeX Xtra  
 
0.25% wt/vol riboflavin 5’-monophosphate, saline  
HPMC, hydroxypropyl methylcellulose 
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FIGURE LEGENDS 508 
 509 
Figure 1  510 
(A) Iontophoresis schematic showing a riboflavin-filled corneal well housing a 511 
negative electrode with the return electrode connected to a needle passed into the 512 
vitreous cavity. The riboflavin solution acts as an electrical contact between the 513 
electrode and the eye. The generator self-checks the continuity and a warning signal 514 
sounded in case of current disruption. (B) Slide mounted 35µm tissue sections were 515 
covered in immersion oil with a coverslip placed on top and coupled to the 516 
microscope objective with distilled water. (C) Grey scale two-photon fluorescence 517 
image analysed in ImageJ with 3 box-plots (40 pixels wide) from which to average 518 
the signal (D) in each section. The edges of the images were not analysed to avoid 519 
areas of vignetting (grey scale image formatted to increase brightness and clarity). 520 
  521 
 522 
Figure 2  523 
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Fluorophore migration within the corneal section investigated with serial 524 
images of the same tissue location at time = 1, 2 and 3 minutes (A-C). Dark 525 
circles are air bubbles within the oil overlying the tissue. All images have been 526 
formatted to increase brightness by the same amount to improve view. (D) 527 
Corresponding TPF signal across samples. Note the loss of the epithelial 528 
peak as riboflavin moves into the stroma. 529 
 530 
Figure 3  531 
Color photographic globe and section examples from each group tested 532 
allowing naked eye comparative view of riboflavin absorption through the 533 
cornea into the anterior chamber. Upper row: Sagittal sections of treated 534 
globes mounted on a cryostat during section preparation. Lower row: 35 μm 535 
corneal sections prepared and laid on white paper for photographic contrast 536 
(visible shadows indicate section lifting off paper). (A) negative control; (B) 537 
positive control (epithelium-off) 0.1% riboflavin 30 minutes; (C) Ribocross TE 538 
0.125% 30 minutes; (D) MedioCross TE 0.25% 30 minutes; (E) ParaCel 539 
0.25% 4 minutes, VibeX Xtra 0.25% 6 minutes; (F) Ricrolin + 0.1% 1 mA 5 540 
minutes iontophoresis. 541 
 542 
 543 
 544 
Figure 4 545 
Two-photon fluorescence images of tissue sections (grey scale). (A) negative 546 
control (B) positive control (epithelium-off) 0.1% riboflavin 30 minutes; (C) 547 
Ribocross TE 0.125% 30 minutes; (D) MedioCross TE 0.25% 30 minutes; (E) 548 
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ParaCel 0.25% 4 minutes, VibeX Xtra 0.25% 6 minutes; (F) Ricrolin + 0.1% 1 549 
mA 5 minutes iontophoresis. e, epithelium; DM Descemet’s membrane; †, 550 
Ribocross TE ‘riboflavin film’ on top of epithelium. All mages have been 551 
formatted to increase brightness by the same amount to improve view. DM 552 
scroll artifact visible in some preparations. 553 
 554 
 555 
Figure 5 556 
Mean concentrations (standard deviation error bars) of riboflavin achieved 557 
using different transepithelial protocols, compared with epithelium-off 558 
absorption (n = 5 for each protocol). Shaded box denotes epithelium. 559 
 560 
Supplementary figure S1 561 
Section preparation. (A) Globe adhered onto specimen stage (with optimal 562 
cutting temperature (OCT) compound) and secured within cryostat chuck. 563 
Yellow cornea visible with white crystalline lens marked with ’96.’ Note 564 
disrupted posterior segment from relieving incision made prior to immersion in 565 
liquid nitrogen to prevent anterior globe splitting (white arrow). (B) 35 µm 566 
whole-globe section laid on blade platform. (C) Lens and aqueous brushed 567 
away leaving sclero-corneal shell (arrow-head) and iris (arrows). (D) Blade 568 
used to cut cornea out before meticulously brushing away attached ice on the 569 
back. Note slight corneal crimp from suction well (*). The surface riboflavin 570 
film - measured by Wollensak et al.29 at up to 300 µm in cellulose-containing 571 
formulations - was also brushed away (Ribocross TE film was particularly 572 
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adherent to the epithelium and was still present on imaging despite attempts 573 
to remove it). 574 
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 576 
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